| QXJ21800.1 |
ABC_transporter_ATP-binding_protein |
BGC0002370.2 |
NRPS:Type I |
45.0 |
95.1 |
174.0 |
1.32e-53 |
| WP_141576251.1 |
ABC_transporter_ATP-binding_protein |
BGC0002686.2 |
NRPS:Type I |
46.0 |
96.2 |
171.0 |
3.31e-52 |
| QXJ26483.1 |
ABC_transporter_ATP-binding_protein |
BGC0002370.2 |
NRPS:Type I |
36.0 |
95.8 |
110.0 |
5.46e-29 |
| AAQ82562.1 |
FscTI |
BGC0000034.5 |
NRPS:Type I+PKS |
36.0 |
91.3 |
106.0 |
1.45e-26 |
| QDJ74277.1 |
ATP-binding_protein |
BGC0002109.3 |
NRPS:Type I |
35.0 |
90.9 |
103.0 |
1.13e-25 |
| OAP25822.1 |
Daunorubicin/doxorubicin_resistance_ATP-binding_protein_DrrA |
BGC0001658.3 |
PKS |
34.0 |
91.6 |
102.0 |
2.47e-25 |
| BAO66521.1 |
ABC_transporter |
BGC0000042.5 |
PKS |
35.0 |
91.3 |
100.0 |
2.39e-24 |
| BAP34737.1 |
ABC-type_multidrug_transport_system |
BGC0000078.5 |
PKS |
33.0 |
91.3 |
100.0 |
2.94e-24 |
| EPH46600.1 |
putative_Daunorubicin/doxorubicin_resistance_ATP-binding_protein_DrrA |
BGC0001519.5 |
NRPS:Type I+PKS |
33.0 |
90.5 |
99.0 |
7.15e-24 |
| QEO74990.1 |
omn15 |
BGC0002078.2 |
NRPS:Type I |
35.0 |
91.3 |
98.0 |
9.91e-24 |
| QNH67555.1 |
Cip27 |
BGC0002108.3 |
NRPS:Type I |
33.0 |
90.5 |
97.0 |
2.08e-23 |
| QBG38790.1 |
Atr29 |
BGC0001975.4 |
NRPS:Type I |
33.0 |
90.5 |
96.0 |
5.54e-23 |
| sipT2 |
|
BGC0001452.5 |
PKS |
33.0 |
91.6 |
91.0 |
4.69e-21 |
| AWR88401.1 |
putative_ABC_transporter_ATP-binding_protein |
BGC0001522.5 |
PKS |
33.0 |
91.6 |
91.0 |
4.69e-21 |
| QQZ01605.1 |
ABC_transporter |
BGC0002498.3 |
other:other |
36.0 |
85.6 |
89.0 |
3.39e-20 |
| BAW35619.1 |
putative_ABC_transporter |
BGC0002357.3 |
PKS+other:other |
35.0 |
84.8 |
87.0 |
1.56e-19 |
| ATY72535.1 |
iron_complex_transport_ATP-binding_protein |
BGC0001574.5 |
NRPS:Type I |
32.0 |
93.9 |
79.0 |
7.77e-17 |